Axsome Therapeutics, Inc. (AXSM)
NASDAQ · Healthcare
Axsome Therapeutics, Inc. Balance Sheet 2022–2025
| Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | |
|---|---|---|---|---|
| Assets | ||||
| Total Assets | 689.8M | 568.5M | 588.2M | 331.5M |
| Cash & Equivalents | 322.9M | 315.4M | 386.2M | 200.8M |
| Liabilities | ||||
| Total Liabilities | 601.5M | 511.5M | 397.3M | 221.9M |
| Long-Term Debt | 117.7M | 180.7M | 178.1M | 94.3M |
| Equity | ||||
| Shareholders' Equity | 88.3M | 57.0M | 191.0M | 109.6M |
Axsome Therapeutics, Inc. Balance Sheet — FAQ
Axsome Therapeutics, Inc. (AXSM) balance sheet over the last 4 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see AXSM's balance sheet history?
The chart and table above show Axsome Therapeutics, Inc.'s balance sheet by year and by quarter, including the growth rate.